-
Yingli Pharmaceutical's KRAS inhibitor is approved for clinical use in the U.S.
Time of Update: 2021-08-15
Transfer from | Pharmaceutical Mission HillsOn July 16, Yingli Pharmaceuticals announced that its self-developed new KRAS G12C inhibitor YL-15293 was approved by the US FDA for clinical trials.
Reference materials:[1] Yingli Pharmaceutical YL-15293 obtained clinical trial approval from the US FDA.
-
Drugstore owner sentenced to 4 years imprisonment for misdispensing medicines, compensation 1.1 million
Time of Update: 2021-08-15
According to relevant information, the defendant in this case was the owner of a local pharmacy, Qin Moumou, who taught himself to become a doctor since he was a child, and started a Chinese herbal medicine business without formal medical training and without a business license .
-
Renfu Medicine: Hydromorphone Hydrochloride Injection Passed the Consistency Evaluation of Generic Drugs
Time of Update: 2021-08-15
(hereinafter referred to as "Yichang Renfu", the company holds 80% of its shares) received from the State Drug Administration Regarding the "Drug Supplementary Application Approval Notice" for hydromorphone hydrochloride injection, the drug passed the consistency evaluation .
-
Hengrui Medicine: HRS2398 tablets were approved for drug clinical trials
Time of Update: 2021-08-15
have recently received the approval of the State Food and Drug Administration to issue a "Drug Clinical Trial Approval Notice" for HRS2398 tablets, and clinical trials will be launched in the near future.
-
When will China Pharmaceuticals release a PDA
Time of Update: 2021-08-15
Is there something like PDA technical report that can be inherited and promoted?And the technological level of the industry is advancing, ha ha .
-
Biotech BAT6005 injection obtained clinical trial approval
Time of Update: 2021-08-15
TIGIT is an immunoglobulin superfamily protein, which is highly expressed on the surface of activated NK cells, CD4+ T cells, CD8+ T cells and immunosuppressive Tregs .
-
Nuotai Bio-Etibatide Injection Obtained Drug Registration Certificate
Time of Update: 2021-08-15
On August 4, Nuotai Biopharmaceuticals announced that it had recently received the "Drug Registration Certificate" (certificate number: 2021S00797) for eptifibatide injection (specification: 10ml:20mg) approved and issued by the State Food and Drug Administration .
-
Jiahe Bio-CDK4/6 Inhibitors Approved for Phase 3 Clinical Treatment of Advanced Breast Cancer
Time of Update: 2021-08-15
On July 20th, Jiahe Bio-Bio announced that its GB491 has obtained the National Medical Products Administration (NMPA) clinical trial implied license and approved two phase III clinical trials for breast cancer treatment .
-
mTOR-targeted inhibitors receive FDA priority review qualifications
Time of Update: 2021-08-15
▲Efficacy data of the AMPECT registered trial (picture source: Aadi Bioscience's official website)Note: The original text has been deletedReference materials:[1] Aadi Bioscience Announces FDA Acceptance and Priority Review for the New Drug Application of Fyarro™ for the Treatment of Advanced Malignant PEComa.
Retrieved July 26, 2021, from https:// 07/26/2268451/0/en/Aadi-Bioscience-Announces-FDA-Acceptance-and-Priority-Review-for-the-New-Drug-Application-of-Fyarro-for-the-Treatment-of-Advanced- Malignant-PEComa.
-
Betta Pharmaceuticals ``Ensatinib'' intends to give priority to the review of the first-line treatment of ALK-positive NSCLC
Time of Update: 2021-08-15
At the WCLC Presidential Symposium in August 2020, the global multicenter phase III clinical (eXalt3) results of Ensatinib for the first-line treatment of ALK-positive NSCLC patients were announced for the first time .
-
What is the guidance of the clinical value of drugs to guide the development of anti-tumor drugs?
Time of Update: 2021-08-15
In July this year, China's CDE issued the "Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value" .
For the first time, this document clearly defines the focus of the clinical value of drugs selected by our country, which are the above six aspects .
-
Legendary curtain call!
Time of Update: 2021-08-15
Although as a company with annual sales of nearly 100 billion yuan, Yangtze River Pharmaceutical has not yet been listed.
Xu Jingren also revealed that Yangtze River Pharmaceutical will also invest more than 4 billion yuan in Chinese medicine.
-
Hengrui Medicine's HR19003 patch was approved for clinical use
Time of Update: 2021-08-15
On August 5, Hengrui Pharmaceuticals issued an announcement stating that the company has recently received the "Notice of Drug Clinical Trial Approval" for the HR19003 patch approved by the National Medical Products Administration, agreeing to use this product for post-herpetic neuralgia.
-
Drug Evaluation Center of the State Food and Drug Administration: 29 generic drug reference preparations have not passed the review
Time of Update: 2021-08-15
The original text is as follows:Notice on Publicly Soliciting Opinions on the "List of Reference Preparations of Chemical Generic Drugs (Forty-seventh Batch)" (Draft for Solicitation of Comments)According to the "Announcement on the Selection and Determination Procedures for the Publication of Chemical Generic Drug Reference Preparations" issued by the National Bureau on March 28, 2019 (No.
-
Olympic Games, Takeda and China's MNC
Time of Update: 2021-08-14
Let’s analyze Hengrui Pharmaceuticals, BeiGene, and Xinhua from the three dimensions of commercialization capabilities, globalization pace, and capitalization The 3 most promising Chinese pharmaceutical companies of Dabio .
-
GlaxoSmithKline's chronic hepatitis B treatment drug is planned to be included in breakthrough treatment products
Time of Update: 2021-08-14
The results showed that in patients treated with GSK3228836 at a dose of 300 mg, regardless of whether they had previously received nucleotide analog (NA) treatment, the level of hepatitis B surface antigen (HBsAg) was reduced .
-
Three research strategies, old cups, new wines, old medicines, new vitality
Time of Update: 2021-08-14
Based on this, some researchers have developed a fast and efficient strategy for new use of old drugs, which consists of 6 calculation modules and 2 breast cancer brain metastasis experimental modules (Figure 1) .
-
Guiding Principles for Research on Immunogenicity of Low Molecular Weight Heparin Generic Drugs Released
Time of Update: 2021-08-14
On August 6, CDE's official website released the "Guiding Principles for Research on the Immunogenicity of Low Molecular Weight Heparin Generic Drugs (Trial)" . The original text is as follows:The or
-
Increased squeeze competition?
Time of Update: 2021-08-14
810 ，DTP：，DTP；，，DTP 。，“” 。DTP：，，，？ ，，DTP10， 。DTP，DTP 。 DTPVS DTP！ ，DTP 。、、、，、、 。 According to the definition of the "National Specialty Drug Association" in the US market where the specialty drug market is more developed, DTP pharmacy refers to a national licensed pharmacy that only provides or mainly provides drugs for patients with serious health problems that require complex treatment .
-
Three licensed pharmacists were revoked due to registration certificate
Time of Update: 2021-08-14
According to Article 36 (2) of the "Administrative Measures for the Registration of Licensed Pharmacists", personal bad information is recorded in the National Licensed Pharmacist Registration Management Information System .
